The FDA approved a new breast cancer drug from Roche, teeing up the launch of a medicine the company has said could become ...
A proposal by the Trump administration to cap the amount of time foreign students and scholars can spend in the country has ...
A free subscriber-only workspace near Union Square to work and connect amid the bustle of the JPM Healthcare Conference.
The acting director of NIAID, John Powers III, will become the permanent director, the agency announced Monday.
How obesity medications may become the next big battleground over access to medicines in lower-income countries.
Biotech is having a good year, though you wouldn't necessarily know it from how investors are treating positive clinical data ...
During July and August 2025, approximately 1 in 10 U.S. adults reported taking a GLP-1 medication during the previous year ...
Joe Hancock, the owner of a family plumbing and heating business in Frankfort, Ky., immediately thought it was a bad sign ...
A psychedelic drug from Helus Pharma improved depression in a study, but is facing safety questions with a number of serious ...
Apple and OpenEvidence are launching a study based around an experimental AI-powered health chat app, hinting at possible new ...
It doesn’t have quite the same ring to it as “Medicare for All.” But House Dems have coalesced around a policy priority to ...
The FDA has rejected ivonescimab, a treatment for a type of lung cancer developed by U.S. biotech Summit Therapeutics and the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results